2002 Helix Award to be Presented at BIO CEO & Investor Conference

Washington, D.C. (February 15, 2002) – The seventh annual Helix Award will be presented on February 21 at the Biotechnology Industry Organization’s CEO & Investor Conference at the Waldorf-Astoria Hotel in New York. The Helix Award recognizes a biotechnology company that demonstrated outstanding leadership in product development, economic growth and corporate citizenship in 2001. The Helix Award will be presented in two categories – emerging and large-cap companies.

The Helix Award is presented by the Long Island Life Sciences Initiative (LILSI) and is jointly sponsored by BIO, Stony Brook University and The Center for Biotechnology at Stony Brook University.

The award competition is open to public and private U.S., or foreign-based biotechnology companies. An independent panel of distinguished judges representing the biotechnology community reviews nominees, and KPMG LLP tabulates the results. Award recipients will be announced during the luncheon keynote address on Thursday, Feb. 21.

Past recipients of the award include The Collaborative Bioalliance (1996), Regeneron Pharmaceuticals (1997), Biogen (1998), Immunex (1999), Genentech Inc. (2000), and OSI Pharmaceuticals, Inc. (2001).

LILSI is a not-for-profit trade association created to address issues of strategic importance to the biotechnology, pharmaceutical, medical device and life science technology-based industries. LILSI advocates on behalf of public policy that will improve the Long Island region's business climate for life science companies and enhance the research and business infrastructure that is vital to their success. More information on LILSI can be found at

BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology products. For more information, please visit our Web site,

# # #